The members of the Cognos Therapeutics, Inc. (Cognos) Neuro-Oncology Board are renowned medical experts in their fields. They have multidisciplinary expertise in translational research and affinity with pharma/drug/device development. Their affiliations are global and they have broad network associations in their respective medical communities.
The Cognos Neuro-Oncology Board is an advisory organ for the executive board of Cognos. The Neuro-Oncology Board provides advice from a clinical point of view about the design, context, and content of Cognos’ ongoing research and product development. In addition, the Neuro-Oncology Board advises Cognos on project proposals as they relate to internal and external funding efforts by the company. The Neuro-Oncology Board informs Cognos about relevant new clinical insights and developments.